Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
2021 · Gut · 1,364 citations
https://doi.org/10.1136/gutjnl-2020-323020
K
Kai Ming Chow
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
278
Papers
9.8K
Citations
51
h-index
136
i10-index
Kai Ming Chow is an academic researcher from The Royal Melbourne Hospital. The author has contributed to research in topics: Dialysis and Renal Disease Management & Chronic Kidney Disease and Diabetes & Central Venous Catheters and Hemodialysis. The author has an h-index of 51, co-authored 237 publications.
ORCID: 0000-0001-5310-5197Papers by this author
worksISPD peritonitis guideline recommendations: 2022 update on prevention and treatment
2022 · Peritoneal Dialysis International · 610 citations
https://doi.org/10.1177/08968608221080586
Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside
2005 · European Journal of Clinical Microbiology & Infectious Diseases · 176 citations
https://doi.org/10.1007/s10096-005-0021-y
ISPD Catheter-related Infection Recommendations: 2023 Update
2023 · Peritoneal Dialysis International · 123 citations
https://doi.org/10.1177/08968608231172740
2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report
2020 · Kidney International Reports · 24 citations
https://doi.org/10.1016/j.ekir.2020.05.001
Ethical Issues in Kidney Transplant and Donation During COVID-19 Pandemic
2022 · Seminars in Nephrology · 7 citations
https://doi.org/10.1016/j.semnephrol.2022.07.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat